{"success":true,"data":{"pressRelease":{"id":"170203","rtpr_id":"nPn8x9PNja-20261015","ticker":"PTCT","exchange":"NASDAQ","all_tickers":["PTCT"],"title":"PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026","author":"PR Newswire","published_at":"2026-10-15T12:00:01.686Z","article_body":"PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026\nPR Newswire\n\nWARREN, N.J., Oct. 15, 2026\n\nWARREN, N.J., Oct. 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:\nPTCT) announced today that the company will host a webcast conference call to\nreport its third quarter 2026 financial results and provide a business update\non Thursday, Oct. 29, 2026, at 4:30 p.m. ET.\n\nTo access the live webcast, please visit the \"Events & Presentations\" page\nwithin the Investors section of the PTC website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=3801058777&u=https%3A%2F%2Fir.ptcbio.com%2Fevents-presentations&a=PTC+website)\n. A replay of the webcast will be available on the PTC website for 30 days\nfollowing the event. To participate via phone, please register in advance here\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=1452680185&u=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI4a77b9c29712458393bcc69f7a902b1f&a=here)\n to receive dial-in details.\n\nAbout PTC Therapeutics, Inc.\nPTC is a global biopharmaceutical company dedicated to the discovery,\ndevelopment and commercialization of clinically differentiated medicines for\nchildren and adults living with rare disorders. PTC is advancing a robust and\ndiversified pipeline of transformative medicines as part of its mission to\nprovide access to best-in-class treatments for patients with unmet medical\nneeds. The company's strategy is to leverage its scientific expertise and\nglobal commercial infrastructure to optimize value for patients and other\nstakeholders. To learn more about PTC, please visit www.ptcbio.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=3261526106&u=http%3A%2F%2Fwww.ptcbio.com%2F&a=www.ptcbio.com)\n and follow us on LinkedIn, X, Facebook and Instagram.\n\nFor more information, please contact:\n\nInvestors:\nEllen Cavaleri\n+1 (615) 618-6228\necavaleri@ptcbio.com (mailto:ecavaleri@ptcbio.com)\n\nMedia:\nJeanine Clemente\n+1 (908) 912-9406\njclemente@ptcbio.com (mailto:jclemente@ptcbio.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-third-quarter-2026-financial-results-on-thursday-oct-29-2026-302909259.html\n(https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-third-quarter-2026-financial-results-on-thursday-oct-29-2026-302909259.html)\n\nSOURCE PTC Therapeutics, Inc.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS678550/PTC-LOGO-Logo-Logo.jpg?id=OA3019380\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn8x9PNja-20261015","title":"PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026","author":"PR Newswire","ticker":"PTCT","created":"2026-10-15T12:00:01.686Z","tickers":["PTCT"],"exchange":"NASDAQ","article_body":"PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026\nPR Newswire\n\nWARREN, N.J., Oct. 15, 2026\n\nWARREN, N.J., Oct. 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:\nPTCT) announced today that the company will host a webcast conference call to\nreport its third quarter 2026 financial results and provide a business update\non Thursday, Oct. 29, 2026, at 4:30 p.m. ET.\n\nTo access the live webcast, please visit the \"Events & Presentations\" page\nwithin the Investors section of the PTC website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=3801058777&u=https%3A%2F%2Fir.ptcbio.com%2Fevents-presentations&a=PTC+website)\n. A replay of the webcast will be available on the PTC website for 30 days\nfollowing the event. To participate via phone, please register in advance here\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=1452680185&u=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI4a77b9c29712458393bcc69f7a902b1f&a=here)\n to receive dial-in details.\n\nAbout PTC Therapeutics, Inc.\nPTC is a global biopharmaceutical company dedicated to the discovery,\ndevelopment and commercialization of clinically differentiated medicines for\nchildren and adults living with rare disorders. PTC is advancing a robust and\ndiversified pipeline of transformative medicines as part of its mission to\nprovide access to best-in-class treatments for patients with unmet medical\nneeds. The company's strategy is to leverage its scientific expertise and\nglobal commercial infrastructure to optimize value for patients and other\nstakeholders. To learn more about PTC, please visit www.ptcbio.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4798081-1&h=3261526106&u=http%3A%2F%2Fwww.ptcbio.com%2F&a=www.ptcbio.com)\n and follow us on LinkedIn, X, Facebook and Instagram.\n\nFor more information, please contact:\n\nInvestors:\nEllen Cavaleri\n+1 (615) 618-6228\necavaleri@ptcbio.com (mailto:ecavaleri@ptcbio.com)\n\nMedia:\nJeanine Clemente\n+1 (908) 912-9406\njclemente@ptcbio.com (mailto:jclemente@ptcbio.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-third-quarter-2026-financial-results-on-thursday-oct-29-2026-302909259.html\n(https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-third-quarter-2026-financial-results-on-thursday-oct-29-2026-302909259.html)\n\nSOURCE PTC Therapeutics, Inc.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS678550/PTC-LOGO-Logo-Logo.jpg?id=OA3019380\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-15T12:00:01.740562149Z","server_sent_at_ms":1792065601740},"received_at":"2026-10-15T12:00:01.790Z","source_url":"https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-third-quarter-2026-financial-results-on-thursday-oct-29-2026-302909259.html"},"analysis":{"id":"158402","press_release_id":"170203","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"PTC Therapeutics announced it will report third quarter 2026 financial results and provide a business update on Thursday, Oct. 29, 2026, at 4:30 p.m. ET via webcast conference call.\n\nThe release is a routine scheduling notice with no financial figures, guidance, or operational news.\n\nA webcast replay will be available on the company's investor relations site for 30 days following the event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar item: PTCT Q3 2026 earnings call set for Oct. 29 at 4:30 p.m. ET."},"keyFigures":{},"namedEntities":{"people":[{"name":"Ellen Cavaleri","role":"Investor Relations contact"},{"name":"Jeanine Clemente","role":"Media contact"}],"products":[],"companies":[{"name":"PTC Therapeutics, Inc.","ticker":"PTCT"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a scheduling notice for an upcoming earnings call with no results or guidance contained in it. No new financial or operational information."},"tickerRelevance":{"others":[],"primary":"PTCT"},"globalImportance":5,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap biotech","eventGravity":"earnings-date-notice-only","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"PTC Therapeutics announced it will report third quarter 2026 financial results and provide a business update on Thursday, Oct. 29, 2026, at 4:30 p.m. ET via webcast conference call.\n\nThe release is a routine scheduling notice with no financial figures, guidance, or operational news.\n\nA webcast replay will be available on the company's investor relations site for 30 days following the event.","key_figures":{},"named_entities":{"people":[{"name":"Ellen Cavaleri","role":"Investor Relations contact"},{"name":"Jeanine Clemente","role":"Media contact"}],"products":[],"companies":[{"name":"PTC Therapeutics, Inc.","ticker":"PTCT"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-15T12:00:18.837Z","global_importance":5,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap biotech","eventGravity":"earnings-date-notice-only","issuerAuthored":true}},"durationMs":3761,"modelName":"glm-5.3-flashx"}}